16 Feb, 2026
XERF Officially Debuts in Indonesia, Maharva Clinic Becomes the First to Adopt This Latest Skin Tightening Technology.
idsMED Indonesia
09 Mar, 2026
Surabaya, February 15, 2026 - The latest generation skin tightening technology, XERF by Cynosure Lutronic, has officially debuted in Indonesia through a strategic collaboration between idsMED Aesthetics Indonesia and Maharva Clinic, which becomes the first clinic in Indonesia to adopt this technology.
The inauguration took place at Maharva Clinic and was marked by ribbon-cutting ceremony as the official symbol of XERF's entry into the Indonesian aesthetic market. The ceremony was conducted by dr. Aji Bayu Chandra, M.Biomed, Clinic Owner of Maharva Clinic, together with the management team of idsMED Aesthetics Indonesia, and was witnessed by invited guests from the media and influencers. This moment marks a new milestone in the development of non-invasive aesthetic treatment technology in Indonesia.
Developed by Cynosure Lutronic, a South Korea-based aesthetic technology company, XERF is the latest skin tightening technology that has received FDA approval, reaffirming its global standards of safety and effectiveness. XERF introduces the world's first multi-frequency monopolar RF treatment and is the only monopolar RF technology that utilizes two wavelengths simultaneously, namely 6.78 MHz and 2 MHz. This combination of frequencies enables deeper and more precise energy delivery to targeted areas, helpin to achieve smoother and firmer skin more optimally.
As part of the global portfolio of Cynosure Lutronic, XERF is positioned as a premium non-surgical solution with minimal downtime, addressing the growing market demand for safe, effective, and science-based skin rejuvenation procedures amid the significant growth of the non-invasive aesthetic treatment segment in Indonesia.
The collaboration between idsMED Aesthetics Indonesia and Maharva Clinic is expected to expand access to the latest aesthetic technologies while addressing the market's increasing preference for optimal result through non-invasive approaches. The following are official statements from representatives involved in this launch.
Through this launch, Andy Rahardja, Vice President of idsMED Aesthetics Indonesia, stated :
"Indonesia is a rapidly growing aesthetic market, particularly in the segments of non-invasive treatments and skin tightening. The introduction of XERF by Cynosure Lutronic is part of our strategic vision to bring global technologies that are relevant to the needs of the Indonesian market. We are proud to collborate with Maharva Clinic as the first clinic to adopt XERF and become a strategic partner in elevating science-based aesthetic service standards in Indonesia."
On the same occasion, Marisa Theresia, Head od Aesthetics at idsMED Indonesia, added :
"XERF by Cynosure Lutronic offers differentiation through next-generation radiofrequeny technology that enables more precise and effective energy distribution while maintaining patient comfort. Clinically, this technology is positioned as a premium skin tightening solution with measureable results and minimal downtime. Our collaboration with Maharva Clinic marks the beginning of our long-term commitment to supporting the implementation of high-standard technology in Indonesia."
Representing the clinic, dr Aji Bayu Chandra, M.Biomed, Owner of Maharva Clinic stated :
"As a clinic that prioritizes science-based and results-driven treatments, we chose XERF because it aligns with Maharva Clinic's philosophy of provideing technologies that are safe, proven, and deliver real benefits to patients. We believe the presence of XERF will expand the options for non-invasive skin tightening treatments in Indonesia while strengthening our commitment to delivering the best aesthetic solutions."
This launch marks a strategic step in bringing global skin tightening technology to Indonesia and further strengtens the collaboration between distributors, international principals, and leading clinics in elevating the standards of the national aesthetic industry.
Share this article
idsMED Indonesia